CNSP
CNS Pharmaceuticals Inc
NASDAQ: CNSP · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.44% today
Updated 2026-04-30
Market cap
$1.91M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-35.75
Dividend yield
—
52W range
$2 – $17
Volume
0.0M
CNS Pharmaceuticals Inc (CNSP) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $162194.00 | $683333.00 | $7.91M | $15.85M | $8.76M | $13.05M | $1.70M | $8.70M |
| Cash & equivalents | $110543.00 | $282736.00 | $7.24M | $14.04M | $5.00M | $10.06M | $548721.00 | $6.46M |
| Current assets | $162194.00 | $588133.00 | $7.89M | $15.50M | $7.48M | $12.56M | $1.59M | $8.66M |
| Total liabilities | $220726.00 | $1.23M | $311000.00 | $1.91M | $2.14M | $4.92M | $6.13M | $2.52M |
| Current liabilities | $220726.00 | $1.23M | $311000.00 | $1.91M | $2.14M | $4.92M | $6.13M | $2.52M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $-58532.00 | $-549298.00 | $7.60M | $13.95M | $6.62M | $8.13M | $-4.43M | $6.18M |
| Retained earnings | $-219362.00 | $-7.61M | $-11.49M | $-20.95M | $-34.98M | $-50.72M | $-69.57M | $-84.42M |
| Accounts receivable | — | — | — | — | — | — | $0.00 | $882539.00 |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | $334138.00 | — | — | — | — |